Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID 19 hospitalized meta-analysis

Argenziano, 2020 OBSproton pump inhibitors (PPI)controlCOVID 19 hospitalizedNA
163/837 inconclusive
    Ramachandran, 2020 OBSproton pump inhibitors (PPI)controlCOVID 19 hospitalizedNA
    46/249 safety concern
    • statistically significant 1.3-fold increase in deaths (PE)
    • statistically significant 1.5-fold increase in ventilation (PE)
    Zhang, 2020 OBSproton pump inhibitors (PPI)controlCOVID 19 hospitalizedNA
    29/29 no results
      No death in the proton pump inhibitor group.

      COVID-19 severe or critically meta-analysis

      Ming Zhong, 2020
      RCTalpha lipoic acidstandard of careCOVID-19 severe or criticallyhigh
      8/9 inconclusive

        PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
        Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).